TP53 and astrocytoma (excluding glioblastoma): Among WHO grade 4 IDH mutant astrocytomas, p53 protein overexpression was noted in 87.5% (7/8 cases) whereas among IDH wildtype glioblastomas, p53 overexpression was noted in 69.1% (56/81 cases).